New Leaf Venture led a $20m Series C round in Flosonics Medical.

New Leaf Venture, a venture capital firm, led a $20m Series C round in Flosonics Medical, a medical device company, with participation from Genesys Capital, iGan Partners and Arboretum Ventures. "Vijay Lathi, an experienced MedTech investor with a focus on data convergence and guiding growth-stage companies, will join Flosonics Medical’s board of directors. “We are thrilled to have New Leaf Venture Partners lead our Series C round and welcome Vijay Lathi to our board. This investment not only validates our past successes but also enables us to accelerate our plans for expansion and innovation. We are committed to leveraging this funding to further enhance the standard of care for critically ill patients with FloPatch and expand our reach into new markets," Joe Eibl, Flosonics Medical CEO.